PRESS RELEASE
13 August 2026

Axinn Advises Thermo Fisher Scientific On Completed $1.075 Billion Sale Of Microbiology Business To Astorg

AV
Axinn

Contributor

Incisive. Inclusive. Invested. We’re Axinn.

Experienced, tenacious, and always trial-ready, we are committed to understanding complex legal challenges that impact the future of our clients’ businesses, globally.

Focusing on antitrust, intellectual property, and high-stakes litigation, our extensive teams in the U.S. possess deep knowledge and client-side experience across a range of sectors, including technology, healthcare, life sciences, and consumer products.

With a strong culture of diversity, equity, and inclusion, we build relationships with our clients and colleagues alike, helping communities and acting with purpose. Our client service, entrepreneurialism, and inquisitive nature sit at the heart of the firm, enabling us to prioritize client goals and achieve successful outcomes.

Axinn advised Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, on the completed sale of its microbiology business to Astorg, a leading pan-European private equity firm, for approximately $1.075 billion.
United States

Axinn advised Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, on the completed sale of its microbiology business to Astorg, a leading pan-European private equity firm, for approximately $1.075 billion. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing.

The Axinn team included partners James Hunsberger and Mark Alexander and associates Megan Walden, Taylor Aiello, and Leandra Ipiña.

More details can be found here.

Contributor

Incisive. Inclusive. Invested. We’re Axinn.

Experienced, tenacious, and always trial-ready, we are committed to understanding complex legal challenges that impact the future of our clients’ businesses, globally.

Focusing on antitrust, intellectual property, and high-stakes litigation, our extensive teams in the U.S. possess deep knowledge and client-side experience across a range of sectors, including technology, healthcare, life sciences, and consumer products.

With a strong culture of diversity, equity, and inclusion, we build relationships with our clients and colleagues alike, helping communities and acting with purpose. Our client service, entrepreneurialism, and inquisitive nature sit at the heart of the firm, enabling us to prioritize client goals and achieve successful outcomes.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More